EMPOWERING BIOPHARMA
ADVANCEMENT

Unparalleled scientific solutions & cutting-edge CHO and HEK 293 based manufacturing tech

Accelerate your preclinical development with our unmatched scientific expertise, seamless service and adaptability to master every challenge. We guarantee exceptional quality, rapid delivery, and cost-effective solutions, all backed by our purposeful commitment to your success.

CORE OFFERINGS

You design it,
we produce it.

From DNA construction and transfection to large-scale protein production, we’ve got you covered. CHO and HEK 293 cell line development done right, from the start. 

See all services

CHO Cell Line Development

Fast and efficient delivery of high-yielding stable CHO clones, with a productivity of over 8 g/L within 8-12 weeks.

cGMP Master Cell Banking

 

Preparation of cGMP-compliant MCB & WCB’s of mammalian suspension cell lines.

HEK 293 Cell Line Development

 

Superior protein quality & yield for challenging to express proteins. Scalable processes with our stable HEK 293 clones.

Process Development USP & DSP

Integrated upstream and downstream process development for yield-maximisation of biologics (> 10 g/L), with desired quality, purity and scalability. Up to 200 Liter Scale.

Cell Host Technologies

Outlicensing of superior cell hosts:
CHOExpress® & HEKExpress®, cell line generation with best in class transposon technology.

Biosimilars

 

Portfolio of high-producing biosimilar cell lines and processes, off-the-shelf and generation of such from scratch. Biosimilarity optimisation of your recombinant cell line.

OUR TECHNOLOGIES

Reliable solutions for CHO and HEK 293 that deliver.

CHO and HEK 293 technologies, combined with biosimilar development, drive high-yield protein expression and optimized biosimilarity. Whether off-the-shelf or custom-built, our solutions empower your development with state of the art technology. 

OUR TECHNOLOGIES

Reliable solutions for CHO and HEK 293 that deliver.

CHO and HEK 293 technologies, combined with biosimilar development, drive high-yield protein expression and optimized biosimilarity. Whether off-the-shelf or custom-built, our solutions empower your development with state of the art technology. 

Cell Host Technologies

Outlicensing of superior cell hosts:
CHOExpress® & HEKExpress®, cell line generation with best in class transposon technology.

Biosimilars

 

Portfolio of high-producing biosimilar cell lines and processes, off-the-shelf and generation of such from scratch. Biosimilarity optimisation of your recombinant cell line.

WHY EXCELLGENE ?

Cutting-Edge Tech

Robust and fast-growth perfected cells, cost-effective, and time-saving solutions.

1
2

Decades of Expertise

40+ years of research and industrial excellence in mammalian cell culture based manufacturing, problem-solving approaches, reliable delivery on time.

Client-First Approach

Trusted, adaptable, and transparent partnership, accompanying you at every challenge.​

​

3

WHY EXCELLGENE ?

1

Cutting-Edge Tech

Robust and fast-growth perfected cells, cost-effective, and time-saving solutions.

2

Decades of Expertise

40+ years of research and industrial excellence in mammalian cell culture based manufacturing, problem-solving approaches, reliable delivery on time.

3

Client-First Approach

Robust and fast-growth perfected cells, cost-effective, and time-saving solutions.

ExcellGene has a very deep understanding of the nuances of CHO cell clone development. We have seen in multiple projects that their thorough process ensures that each step is done right.

David S.Block

CEO, Gliknik Inc.

ExcellGene’s expertise and troubleshooting were pivotal in advancing our multi-specific therapeutic protein through CHO cell line development. Their commitment to quality, timely delivery, and clear communication ensured a seamless collaboration. Highly recommended!

Luigi Colombo

CEO, EPOK Therapeutics Inc.

For an academic vaccine developer like me, it is of utmost importance to build our research program with the support of a biotech company with which we have built a high level of confidence and trust. Communication has to be easy and transparent, and the delivery of our product has to be in purity and quantity as needed, so that the timing for starting a clinical trial matches our plans. This is exactly the experience I have with ExcellGene. In addition to it, as a science-driven company, they bring innovative and creative solutions to complex problems.

François Spertini, MD

Prof, Centre Hospitalier Universitaire Vaudois (CHUV)

Join us at our conferences and be a part of the innovation revolution!

CPHI
Bioproduction

08th-10th October 2024
booth 3D117
Fiera Milano
Milan, ITALY

Festival of Biologics

15th-17th October 2024
Hall 1
Messe Basel, SWITZERLAND

PEGS EU

5th-7th November 2024
Montjuic Palau de Congressos
Fira Barcelona, SPAIN

Connect with our latest news and publications.

News & publications

A superior HEK cell line for AAV production

Jun 1, 2023 |

A superior HEK cell line for AAV productionWriter's Insight Derived from ExcellGene's HEKExpress® cells, a widely used cell system known for its transient and stable protein expression, a new host system with superior performance has been developed. This innovative system, cultivated in suspension with chemically defined media, offers remarkable enhancements. A scientific...

read more